Can a 12-Week online program stop diabetes before it starts?

NCT ID NCT07443995

Not yet recruiting Prevention Sponsor: New York University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 12-session virtual program to help adults with prediabetes in the UAE prevent type 2 diabetes. The program covers diet, physical activity, sleep, and stress management, and is led by a health coach from the same cultural background. Thirty participants will attend weekly group sessions online, and researchers will measure how many sessions they attend, along with changes in weight, blood sugar, diet, and activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: adapted diabetes prevention program (behavioral intervention)
What this could lead to: If successful, this could provide a practical, culturally tailored program to help prevent diabetes in at-risk communities.
What could go wrong: This is a very small early feasibility trial with only 30 participants and no control group, so results may not be generalizable. Success depends on attendance and short-term changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIET PREVENTION OF METABOLIC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glucose intolerance Motor Activity prediabetes syndrome Risk Reduction Behavior diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIET PREVENTION OF METABOLIC DISEASES LIFESTYLE RISK REDUCTION PRE-DIABETES

Contacts and locations

Locations

New York University Abu Dhabi

Abu Dhabi, 129188, United Arab Emirates

More trials for these conditions

Other studies related to the condition(s) this trial covers.